立即与延迟用力对接受椎管内镇痛初产妇自然阴道分娩率的影响:一项随机临床试验
这项在6个美国医疗中心进行的实用性随机临床试验纳入2414名≥37周妊娠、接受椎管内镇痛的初产妇,宫口开全时随机分为立即用力组(n=1200)和延迟60分钟用力组(n=1204)。主要结局自然阴道分娩率两组无显著差异(85.9% vs 86.5%;绝对差-0.6%,95%CI -3.4%至2.1%;RR 0.99,95%CI 0.96至1.03)。立即组第二产程平均时长显著缩短(102.4 vs 134.2分钟;平均差-31.8分钟,95%CI -36.7至-26.9,P<.001),但主动用力平均时长显著延长(83.7 vs 74.5分钟;平均差9.2分钟,95%CI 5.8至12.6,P<.001),绒毛膜羊膜炎发生率更低(6.7% vs 9.1%;差值-2.5%,95%CI -4.6%至-0.3%,P=.005),产后出血更少(2.3% vs 4.0%;差值-1.7%,95%CI -3.1%至-0.4%,P=.03)。作者认为,用力时机不影响自然阴道分娩率,这些发现可能有助于在考虑其他母婴结局时决定第二产程用力时机的选择。
要点
- 在接受椎管内镇痛的初产妇中,宫口开全后立即用力与延迟60分钟用力相比,自然阴道分娩率无显著差异(85.9% vs 86.5%;RR 0.99,95%CI 0.96至1.03)。
- 立即用力组第二产程平均时长显著短于延迟组(102.4 vs 134.2分钟;平均差-31.8分钟,95%CI -36.7至-26.9,P<.001)。
- 立即用力组主动用力平均时长显著长于延迟组(83.7 vs 74.5分钟;平均差9.2分钟,95%CI 5.8至12.6,P<.001)。
- 立即用力组绒毛膜羊膜炎发生率显著低于延迟组(6.7% vs 9.1%;差值-2.5%,95%CI -4.6%至-0.3%,P=.005),产后出血更少(2.3% vs 4.0%;差值-1.7%,95%CI -3.1%至-0.4%,P=.03)。
- 新生儿 morbidity 复合结局两组无显著差异(7.3% vs 8.9%;差值-1.6%,95%CI -3.8%至0.5%),会阴裂伤(≥二度)也无显著差异(45.9% vs 46.4%;差值-0.4%,95%CI -4.4%至3.6%)。
适用人群与场景
- 纳入:≥37周妊娠、因自然临产或引产入院、接受椎管内镇痛的初产妇,在宫口开全时随机分组。
- 场景:6个美国医疗中心的产房。
处置流程与药物剂量
- randomization 在宫口开全时进行;立即用力组(n=1200)立即开始用力;延迟用力组(n=1204)被指示等待60分钟。
研究设计与关键结果
- 研究类型:实用性随机临床试验,6个美国医疗中心,2014年5月至2017年12月纳入,计划样本3184例,因中期分析提示主要结局无效而终止招募,实际随机2414例(立即组1200例,延迟组1204例),2404例(99.6%)完成试验,随访至2018年1月4日。
- 人群:初产妇,平均年龄26.5岁,≥37周妊娠,接受椎管内镇痛。
- 主要终点:自然阴道分娩率立即组85.9% vs 延迟组86.5%,无显著差异(绝对差-0.6%,95%CI -3.4%至2.1%;RR 0.99,95%CI 0.96至1.03)。
- 关键次要终点:第二产程平均时长立即组102.4分钟 vs 延迟组134.2分钟,立即组显著缩短(平均差-31.8分钟,95%CI -36.7至-26.9,P<.001);主动用力平均时长立即组83.7分钟 vs 延迟组74.5分钟,立即组显著延长(平均差9.2分钟,95%CI 5.8至12.6,P<.001);绒毛膜羊膜炎立即组6.7% vs 延迟组9.1%,立即组显著降低(差值-2.5%,95%CI -4.6%至-0.3%,P=.005);产后出血立即组2.3% vs 延迟组4.0%,立即组显著减少(差值-1.7%,95%CI -3.1%至-0.4%,P=.03)。
- 其他次要终点:新生儿 morbidity 复合结局立即组7.3% vs 延迟组8.9%,无显著差异(差值-1.6%,95%CI -3.8%至0.5%);会阴裂伤(≥二度)立即组45.9% vs 延迟组46.4%,无显著差异(差值-0.4%,95%CI -4.4%至3.6%);9个预设次要结局中有5个报告无显著差异。
证据类型、等级与局限
- 证据类型:实用性随机临床试验(RCT),注册号NCT02137200。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于接受椎管内镇痛的初产妇,宫口开全后立即用力或延迟60分钟用力均可考虑,两者自然阴道分娩率无显著差异;作者认为这些发现可能有助于在考虑其他母婴结局时决定第二产程用力时机的选择。
- 立即用力可缩短第二产程总时长,但主动用力时间更长;与延迟用力相比,立即用力与更低的绒毛膜羊膜炎和产后出血发生率相关。
指南或共识出处
- JAMA发表的随机临床试验(NCT02137200)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: It is unclear whether the timing of second stage pushing efforts affects spontaneous vaginal delivery rates and reduces morbidities.
OBJECTIVE: To evaluate whether immediate or delayed pushing results in higher rates of spontaneous vaginal delivery and lower rates of maternal and neonatal morbidities.
DESIGN, SETTING, AND PARTICIPANTS: Pragmatic randomized clinical trial of nulliparous women at or beyond 37 weeks' gestation admitted for spontaneous or induced labor with neuraxial analgesia between May 2014 and December 2017 at 6 US medical centers. The interim analysis suggested futility for the primary outcome and recruitment was terminated with 2414 of 3184 planned participants. Follow-up ended January 4, 2018.
INTERVENTIONS: Randomization occurred when participants reached complete cervical dilation. Immediate group participants (n = 1200) began pushing immediately. Delayed group participants (n = 1204) were instructed to wait 60 minutes.
MAIN OUTCOMES AND MEASURES: The primary outcome was spontaneous vaginal delivery. Secondary outcomes included total duration of the second stage, duration of active pushing, operative vaginal delivery, cesarean delivery, postpartum hemorrhage, chorioamnionitis, endometritis, perineal lacerations (≥second degree), and a composite outcome of neonatal morbidity that included neonatal death and 9 other adverse outcomes.
RESULTS: Among 2414 women randomized (mean age, 26.5 years), 2404 (99.6%) completed the trial. The rate of spontaneous vaginal delivery was 85.9% in the immediate group vs 86.5% in the delayed group, and was not significantly different (absolute difference, -0.6% [95% CI, -3.4% to 2.1%]; relative risk, 0.99 [95% CI, 0.96 to 1.03]). There was no significant difference in 5 of the 9 prespecified secondary outcomes reported, including the composite outcome of neonatal morbidity (7.3% for the immediate group vs 8.9% for the delayed group; between-group difference, -1.6% [95% CI, -3.8% to 0.5%]) and perineal lacerations (45.9% vs 46.4%, respectively; between-group difference, -0.4% [95% CI, -4.4% to 3.6%]). The immediate group had significantly shorter mean duration of the second stage compared with the delayed group (102.4 vs 134.2 minutes, respectively; mean difference, -31.8 minutes [95% CI, -36.7 to -26.9], P < .001), despite a significantly longer mean duration of active pushing (83.7 vs 74.5 minutes; mean difference, 9.2 minutes [95% CI, 5.8 to 12.6], P < .001), lower rates of chorioamnionitis (6.7% vs 9.1%; between-group difference, -2.5% [95% CI, -4.6% to -0.3%], P = .005), and fewer postpartum hemorrhages (2.3% vs 4.0%; between-group difference, -1.7% [95% CI, -3.1% to -0.4%], P = .03).
CONCLUSIONS AND RELEVANCE: Among nulliparous women receiving neuraxial anesthesia, the timing of second stage pushing efforts did not affect the rate of spontaneous vaginal delivery. These findings may help inform decisions about the preferred timing of second stage pushing efforts, when considered with other maternal and neonatal outcomes.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02137200.
参考来源
- Cahill AG, Srinivas SK, Tita ATN, et al. Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial Analgesia: A Randomized Clinical Trial. JAMA. 2018. PMID: 30304425. doi:10.1001/jama.2018.13986
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。